학술논문

Results of a Randomized Open Multicenter Comparative Study of the Tolerability and Safety of Gilenya (fingolimod) in Patients with Remitting Multiple Sclerosis (the GIMN study)
Document Type
Article
Source
In: Neuroscience and Behavioral Physiology. (Neuroscience and Behavioral Physiology, 1 January 2017, 47(1):102-106)
Subject
Language
English
ISSN
1573899X
00970549